Debra Liebert

Debra K.
Liebert is the founder of Calixa Therapeutics, Inc., Nanothera Corp., Sonexa Therapeutics, Inc., and Merada Therapeutics, Inc. She previously worked as the Executive Director of New Product Management at CancerVax Corp.
and as the Managing Director at Domain Associates LLC.
From 2015 to 2024, she served as an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. Prior to that, she held the position of Vice President of Corporate Development at both Trega Biosciences, Inc. and LPL Technologies, Inc. Ms. Liebert obtained an MBA from the University of California, Los Angeles in 2000.
She also holds an undergraduate degree from Clarion University of Pennsylvania, conferred in 1978, and a graduate degree from Duquesne University of The Holy Spirit, conferred in 1981.